Table 2.

Medications for patients with type 2 diabetes

	Insulin (−) (N = 216)	Insulin (+) (N = 86)	p-values
Sulfonylureas (%)	18	4	0.002
Biguanides (%)	25	22	0.662
Alpha-GIs (%)	5	8	0.241
Glinides (%)	3	2	0.817
TZDs (%)	5	4	0.861
DPP4 inhibitors (%)	36	22	0.021
GLP1-R agonists (%)	2	1	0.666
SGLT2 inhibitors (%)	2	0	0.369
ACEIs (%)	4	3	0.775
ARBs (%)	33	41	0.153
Calcium channel blockers (%)	27	46	0.001
Beta-blockers (%)	12	9	0.553
Alpha-blockers (%)	2	2	0.799
Diuretics (%)	7	16	0.014
Statins (%)	29	39	0.076
Fibrates (%)	2	4	0.289
Ezetimibe (%)	5	2	0.280
Uric acid-lowering agents (%)	7	5	0.539
Anti-platelet agents (%)	11	18	0.116

ACEIs angiotensin converting enzyme inhibitors, ARBs angiotensin receptor blockers, DPP4 dipeptidyl peptidase 4, GIs glycosidase inhibitors, GLP1-R glucagon-like peptide 1 receptors, SGLT2 sodium–glucose cotransporter 2, TZDs thiazolidinediones